SPDR Select Sector Fund - Health Care (XLV)

92.85 +1.38 (+1.509%)

IEX Real-Time Price

February 15, 2019 EST.

NYSE Arca :

Prev Close 91.47

Price Open 92.16

Volume: 8.23M

Avg Volume: 9.51M

Market Cap: 19.69B

P/E Ratio -

52 Wk Range 78.74-96.06


FDA creates new accelerated review pathway for generic drug applications (2019-02-15 10:48 SeekingAlpha)

In a statement , FDA commissioner Scott Gottlieb, M.D. announces a new pathway for accelerated view of marketing applications from generic drugmakers for off-patent branded medicines facing no generic competition, a situation characterizing "hundreds" of such drugs that serve small patient …



Shares Outstanding: 212.12M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 4.30

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: 6.07

Return On Equity: 16.66

Profit Margin: N/A

Price History

Beta: 0.98

50-day Moving Avg: 88.67

200-day Moving Avg: 88.12

YTD Change: 8.98

5-day Change: 3.36

1-month Change: 5.03

3-month Change: 2.36

6-month Change: 4.12

1-year Change: 11.22

Revenue Per Share: 0.00

Revenue Per Employee: N/A


Dividend Yield: 1.47

EX-Dividend Date: 2018-12-21

Dividend Rate: 1.36

Company Profile

Name: SPDR Select Sector Fund - Health Care

Exchange: NYSE Arca



Website: http://www.spdrs.com

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.